ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620109 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620109; 2) Community: the network communities that were significantly associated with the response to NSC 620109; 3) Molecule: the relationships between components within communities and NSC 620109; 4) MDR: the compounds that were significantly associated with the NSC 620109.

NSC Compound Enrichment Correlation
NSC 703117 Null 0.0105972823829604 0.25121908
NSC 708559 Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) 0.0105972823829604 0.17394826
NSC 709440 Null 0.0105972823829604 -0.13619166
NSC 710716 Null 0.0105972823829604 0.75932661
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.0105972823829604 0.1965073
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0105972823829604 0.27423741
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0105972823829604 0.500939
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0105972823829604 0.59604406
NSC 732178 Null 0.0105972823829604 0.2129393
NSC 746540 Null 0.0105972823829604 0.61439574
Total:113  Current:38    [First] [Prev] [Next] [Last]